Epofolate

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameEpofolate
Drug Alias NameBMS-753493
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFolate receptor beta antagonistsFolate receptor alpha antagonists
TargetsFolate receptor betaFolate receptor alphaTubulin
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma AgBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol Myers Squibb Srlcompany
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A